Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is the Price Finally Right to Buy InterMune?
Motley Fool
Saturday, August 11, 2012 - 11:19am
tags:
InterMune
Merrimack 2Q loss narrows on drug payments
Yahoo/AP
Saturday, August 11, 2012 - 11:18am
tags:
Merrimack Pharmaceuticals, earnings
How Much Can Vivus, Arena Pharma Charge for Diet Pills?
Minyanville
Friday, August 10, 2012 - 6:38pm
tags:
Vivus, Arena Pharmaceuticals, obesity, Belviq, Qsymia
Mylan receives OK to sell generic Provigil doses
Yahoo/AP
Friday, August 10, 2012 - 6:37pm
tags:
Mylan, Provigil, generics
Biodel's CEO Discusses F3Q12 Results - Earnings Call Transcript
Seeking Alpha
Friday, August 10, 2012 - 6:34pm
tags:
Biodel, earnings
Alexion's Soliris to Merck's Januvia, top 20 generate huge growth
Fierce Pharma
Friday, August 10, 2012 - 6:31pm
tags:
Merck, Alexion, Soliris, Januvia
Roche says Avastin slows brain cancer tumor growth
Reuters
Friday, August 10, 2012 - 6:24pm
tags:
Avastin, Roche, glioblastoma, brain cancer
Seattle Genetics: A Growth-Free Quarter -- and That's OK
Motley Fool
Friday, August 10, 2012 - 6:22pm
tags:
Seattle Genetics, earnings
Pharma Giants Nervous As India Contemplates Regulating Patented Drug Prices
Seeking Alpha
Friday, August 10, 2012 - 6:20pm
tags:
India, patents, JNJ, Merck, Pfizer, Abbott Laboratories
Roche’s Skin Cancer Treatment Delayed By U.K. Drug-Cost Agency
Bloomberg
Friday, August 10, 2012 - 10:09am
tags:
UK, Roche, melanoma, Zelboraf
Hedge Funds Love These 3 High-Growth Drugmakers
Seeking Alpha
Friday, August 10, 2012 - 10:07am
tags:
hedge funds, MAP Pharmaceuticals, Horizon Pharma, Pozen
Icahn accuses Forest of hiding poison pill agreements
Reuters
Friday, August 10, 2012 - 10:05am
tags:
Forest Labs, Carl Icahn, poison pill
GenVec's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Friday, August 10, 2012 - 10:05am
tags:
GenVec, earnings
Vivus Diet Pill Sales May Be Slow Out of the Gate
Minyanville
Friday, August 10, 2012 - 10:04am
tags:
Vivus, obesity, Qsymia
Pfizer's Torisel drug fails in a combination study
Yahoo/Reuters
Friday, August 10, 2012 - 10:03am
tags:
Torisel, Pfizer, renal cell carcinoma
Talon Therapeutics Looks Undervalued Following FDA's Surprise Early Approval
Yahoo/Reuters
Friday, August 10, 2012 - 10:02am
tags:
Talon Therapeutics, FDA, acute lymphoblastic leukemia, Marqibo
Horizon Pharma Announces Second Quarter 2012 Financial Results and Provides Business Update
Yahoo
Friday, August 10, 2012 - 10:01am
tags:
Horizon Pharma, earnings
Medivation 2Q loss narrows on drug payments
Yahoo/AP
Thursday, August 9, 2012 - 10:18pm
tags:
earnings, Medivation
Salix Pharmaceuticals Beats, Announces Licensing Deal
Investors.com
Thursday, August 9, 2012 - 12:30pm
tags:
Salix, earnings
The Top 10 Drug Advertising Spends -- Q1 2012
Fierce Pharma
Thursday, August 9, 2012 - 11:57am
tags:
DTC, advertising

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.